In cancer drug battle, both sides appeal to ethics

Andrea Sloan is dying of ovarian cancer. Having exhausted all standard treatment options, her doctors say her best hope now is a new class of cancer drugs called PARP inhibitors.

Source: http://rss.cnn.com/~r/rss/cnn_health/~3/7IMFrlpaCdU/index.html

for more info site website view